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Background: The aim of this thesis was to perform an extended study of the antibacterial activity of 
selected newly synthesized rhodanine derivatives. In this study, activity against clinical isolates of 
bacterial strains of the genus Staphylococcus and Enterococcus was evaluated. The main part of the 
work also includes the evaluation of the antibacterial activity of one selected substance in 
combination with commercially available antibiotics using the checkerboard method. 
 
Methods: Evaluation of the antibacterial activity of tested substances was performed using the broth 
microdilution method according to EUCAST guidelines (with minor modifications). The activity of 
these substances was evaluated against clinical isolates of bacteria of the genera Staphylococcus and 
Enterococcus and one Staphylococcus aureus MRSA reference strain (ATCC 43300, CCM 4750). For a 
selected compound with a demonstrably promising antistaphylococcal effect, the combined effect of 
this substance was tested with three selected commercially available antibiotics (ciprofloxacin, 
rifampicin, vancomycin) using the checkerboard method. The Staphylococcus aureus MRSA reference 
strain (ATCC 43300, CCM 4750) was used to test the combined antibacterial effect. In order to 
determine the MIC value, three methods of reading the results were chosen, namely 
spectrophotometric detection, reading of the growth of bacteria with the naked eye and reading of 
the colour change of the metabolic indicator alamarBlue. 
 
Results: Nine substances from the group of rhodanine derivatives were tested. These substances 
showed activity mainly against Staphylococcus aureus strains. On the contrary, the lowest activity 
was observed against Enterococcus faecium VRE strain. The selected substance codenamed RHO-y 
showed a synergistic effect in combination with ciprofloxacin at a concentration ratio of 0,25*MIC 
(RHO-y) : 0,125*MIC (ciprofloxacin), as well as an additive effect at a ratio of 0,5*MIC : 0,5*MIC; 
0,25*MIC : 0,5*MIC; 0,125*MIC : 0,5*MIC; 0,0625*MIC : 0,5*MIC and 0,03125*MIC : 0,5*MIC. In 
other concentration ratios, these substances showed only an indifferent effect. In combination with 
rifampicin, RHO-y showed an additive effect in combinations of 0,5*MIC (RHO-y) : 0,25*MIC 
 
 
(rifampicin) and 0,5*MIC : 0,5*MIC. In other concentration ratios, these substances showed only an 
indifferent effect. The combination of RHO-y with vancomycin showed only an indifferent effect in all 
concentration ratios. None of the combinations of RHO-y with commercially available antibiotics 
showed an antagonistic effect. 
 
Conclusion: In advanced testing, nine rhodanine derivatives showed antistaphylococcal activity, 
especially against the Staphylococcus aureus strain. Using the checkerboard method, a synergistic 
effect of RHO-y in combination with ciprofloxacin and an additive effect in combination with 
rifampicin were found. The combination of RHO-y with vancomycin showed only an indifferent 
effect. None of the tested combinations of these substances showed evidence of antagonism. 
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